PLMA_1170x120_10-8-21

O-T-Cs

Law promises big O-T-C savings

Law promises big O-T-C savings

NEW YORK — A provision in the Coronavirus Aid, Relief and Economic Security (CARES) Act, which Congress passed and President Trump signed into law in March, offers a potential boon to consumers and retailers, according to Glaxo­Smith­Kline (GSK), which is one of the largest providers of over-the-counter medications in the world. The provision in the

CHPA issues statement regarding O-T-C measures in COVID-19 legislation

CHPA issues statement regarding O-T-C measures in COVID-19 legislation

WASHINGTON— Consumer Healthcare Products Association (CHPA) president and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act, which among its many sections includes provisions to update and modernize the regulatory system overseeing most over-the-counter (O-T-C) medicines and to restore O-T-C eligibility under tax-preferred HSA and FSA accounts. “During this unprecedented

GlaxoSmithKline, Pfizer close joint venture

GlaxoSmithKline, Pfizer close joint venture

WARREN, N.J. — GlaxoSmithKline said Thursday that it has closed a previously announced joint venture deal with Pfizer Inc. that will combine their respective consumer healthcare businesses. The move will create the world’s largest supplier of over-the-counter medications. The joint venture company will operate as GSK Consumer Healthcare. Pfizer owns a 32% equity stake in

Study: O-T-Cs save health care system billions

Study: O-T-Cs save health care system billions

WASHINGTON — Over-the-counter (O-T-C) medicines save the U.S. health care system nearly $146 billion a year, a new study has found. The report, “Value of O-T-C Medicines to the U.S. Healthcare System,” which was released by the Consumer Healthcare Products Association (CHPA), found that, on average, each dollar spent on O-T-Cs saves the national system